🇺🇸 FDA
Patent

US 6864066

Epithelial protein lost in neoplasm (EPLIN)

expired A61KA61K38/00

Quick answer

US patent 6864066 (Epithelial protein lost in neoplasm (EPLIN)) held by The Regents of the University of California expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K38/00